-
The circadian clock and cancer - it's all in the timing
@CellSystemsCP#AACR18 http://bit.ly/2qJioAN -
Thought-provoking read from
@jaybradner on why the industry’s reconfiguration of cancer R&D is essential.#AACR18 https://lnkd.in/exc6JtV -
In cool science news. In case you missed this from
#AACR18 -@GoogleResearch on their development of an "Augmented Reality Microscope for Cancer Detection"http://bit.ly/2qMxCWe -
Pediatric Oncology Branch’s ACI Dr. Christine Heske gets nice foot traffic for her poster on Ewing’s sarcoma at
#AACR18@NCIResearchCtrpic.twitter.com/3TFlG0EOhh
-
This is new! Single-tube RNA library prep followed by "one click" fully automated bioinformatics. Learn more at Diagenode booth 1220,
#AACR18@Genialis https://loom.ly/99-8aqc -
"We spent 20 years personalizing targeted therapies, and we are now moving toward personalized immunotherapies," says
@DrRoyHerbstYale https://www.cancer.gov/news-events/cancer-currents-blog/2018/pembrolizumab-lung-cancer-first-line …#aacr18#lungcancerpic.twitter.com/NLligQMTQB
-
After 6 months of listening & learning from people across the cancer community, I highlighted some key areas of focus for
#NCIFuture at#AACR18 this week. If you missed it, be sure to check out my blog post: http://bit.ly/2HafSdz -
One of the most interesting
#AACR18 sessions was the Forum on “Is Genome-Informed Cancer Medicine Generating Patient Benefit or Just Hype?,” featuring a debate between@DHymanMD and @VinayPrasadMD. Audio and slides are now available on the meeting webcast: http://webcast.aacr.org/s/2018annual/FO02 …pic.twitter.com/3dPQ0xMgaF
-
HaoRan Tang from our Molecular Oncology group presenting his fantastic work in collaboration with our Drug Discovery Unit on LOX regulation of EGFR & tumour progression/invasion at the last poster session of
#AACR18 pic.twitter.com/JQt88Ldh93
-
Cheri Pasch from our lab presenting her patient-derived organotypic cancer steroid work at
#AACR18. Great work Cheri!!! pic.twitter.com/s0wKWfSqfZ
-
Presenting insights learned and data from the http://ASCproject.org at
#AACR18 now. So much enthusiasm for the approach, lessons learned and ability to conduct in such an exceedingly rare indication. pic.twitter.com/2tgCIhEqGy
-
"Unsolved Mysteries" were among the most interesting sessions at
#AACR18. In the session, "Failure to Translate: The IGF-1R and PI3K Inhibitors," Carlos Arteaga and Valentine Macaulay discussed the challenges presented by these targets. View the webcast: http://webcast.aacr.org/s/2018annual/SS06 … -
The Kyn Team is presenting our IDO/TDO programs at
#AACR18 today. Here is Karen McGovern, VP Drug Discovery, handling the crowd at one of our posters. pic.twitter.com/s5KMWMe0RO
-
#AACR18 highlights: reversing drug resistance in ER-positive breast cancer http://bit.ly/2IXPdoF -
What caught our eye at
#AACR18? Find out in our first-ever list of#PICIPicks: http://bit.ly/2Hh9Dc4#immunotherapy#cancerresearch -
#Immunotherapy dominated the headlines at#AACR18. Our science writer@ArthurBrodsky highlights news on biomarkers, data sharing, and personalized medicine:http://bit.ly/2K9Rxqn -
Congrats to Winship oncologist
@JeanKoffMD who has received an@AACR Lymphoma Research Fellowship. Funding from the two-year grant will support her research project, "B cell repertoire, genetic abnormalities, and outcomes in B cell lymphoma."#AACR18 pic.twitter.com/w2WboFqo82
-
Why I love my patient/advocate friends? They bring everything to the table. Many thanks to
@JFreemanDaily ,@stage4kelly and Sheila for walking#AACR18 scientists through our http://MBCproject.org poster. Data presented from patients? Priceless.pic.twitter.com/jPUiYoQijP
-
Here’s Francesca Chemi from our CEP group with her WICR winning poster at
#AACR18 this week. Congratulations! pic.twitter.com/mLOCOjWcAB
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.